Delivery Order SPE2DB25D3003-SPE2DB25FPXAF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,616.52 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count packages). This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive award to the established pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 14, 2025, with a ceiling value of $10,421.34 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for ultimate completion by July 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's critical...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,144.39 by the Defense Logistics Agency Medical Supply Chain to supply Progesterone 200 mg capsules (100-count) with an ultimate completion date of September 26, 2025. The contract utilizes a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $7,603.70. This firm fixed-price delivery order, which is expected to be completed by August 22, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29,014 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-competitive procurement requiring delivery to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $17,186.02 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $5,700.75 and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $17,049.73 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (30-count) valued at $3,423.48 with a firm fixed price and an ultimate completion date of September 30, 2025. This non-set-aside contract was competitively awarded on September 29, 2025, with performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,208.42 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (30-count units). The contract, awarded on October 31, 2025, is a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it was competitively awarded through open...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXAFDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,481.14 for Progesterone 200 mg capsules (100 count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order operates under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. This contract award demonstrates AmerisourceBergen Drug Corp's established capability to fulfill federal medical supply requirements through open competition and positions the company as a key supplier for hormone treatments and other pharmaceutical products across the Defense Health Agency and broader federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.5k | 8/26/25 |